Author Archive: Jim Greenwood

Jim Greenwood

Jim joined BIO as President & CEO in 2005 after representing the eighth district of Pennsylvania in the U.S. House of Representatives for six terms.  He had worked with BIO while in Congress on stem cell research and other health issues, and has since learned so much about the many applications of the science in food and agriculture and in industrial and environmental biotechnology.

Due to its revolutionary research and development in issues ranging from feeding the world by increasing crop yields to healing the world with new medicines to providing cleaner sources of energy, Jim is a passionate champion for biotechnology. When visiting member companies, he is inspired by executives and scientists who are united in their mission to help patients, farmers and other consumers lead a better life.

Prior to Congress, Jim served in the Pennsylvania House of Representatives and Pennsylvania Senate for six years each.  He and his wife Tina live in historic Washington Crossing, Pennsylvania (where he has participated in the re-enactment of George Washington crossing the Delaware River on Christmas Day in 1776). He enjoys fishing, birding and scuba diving.

You can find him on Facebook at https://www.facebook.com/jamescgreenwood.

Latest Posts

The Presidential Inaugural: BIO Stands Ready to work with President Obama

Jim Greenwood

Today we congratulate President Obama on his swearing-in as President of the United States. BIO looks forward to continuing to work with the president and his administration over the next four years to craft policies that will help create jobs, propel continued innovation, and increase our nation’s competitiveness in the global marketplace. The United States remains the world leader in biotechnology. Our nation’s biotechnology industry is comprised of scientists, entrepreneurs and large and small companies Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

How the Biotechnology Industry Can Combat Doping in Sports

Track

Biotechnology companies work every day to solve some of our biggest global challenges – fighting disease, hunger and pollution. Yet, we in the biotech industry are strongly aware that our products can also be misused in the wrong hands. The same medicines that can be used to help children with devastating genetic deficiencies and growth disorders, or to help a chemotherapy patient combat cancer, can also be abused by healthy athletes to gain an unfair Read More >

Jim's Corner  |  1 Comment  |  Email This Post
Tags: , , , , , ,

New Drug Disposal Law Doesn’t Make Sense

rxpills-btn

Product stewardship is a broad term applied across many industries, encompassing environmental, health, and safety concerns. Companies in each sector of the biotech industry (healthcare, agricultural, and industrial and environmental) have championed stewardship programs for many years – not just because it makes good business sense, but because they believe it is the right thing to do. Within the healthcare space, the impact of pharmaceuticals in the environment has become an issue of emerging debate. Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: ,

Research: Working Together Toward Cures

Jim Greenwood

Modern biomedical innovation and the discovery of new cures and therapies for devastating diseases require robust collaboration and coordination among industry, research institutions and physicians. By bringing together the brightest minds in medical research, our nation’s research enterprise has successfully brought hundreds of new drugs, biologics, and vaccines to market in recent years and developed a wealth of clinical prescribing information. Ongoing research is advancing the fight against some of humanity’s worst scourges, such as Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

20th Anniversary of the BIO International Convention

Jim Greenwood

Next year BIO will celebrate the 20th anniversary of the BIO International Convention April 22-25 in Chicago. From a small beginning, our convention has grown into the most influential biotech meeting in the world, attracting more than 16,500 attendees from 65 countries and providing a wide array of education, exhibits and networking opportunities — including more than 25,000 partnering meetings expected during the 4-day event. As we look forward to the upcoming Convention, I cannot Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , ,